Brief: Protalix Biotherapeutics Announces $20 Million Payment From Chiesi Global Rare Diseases

Protalix BioTherapeutics

18/05/2023 11:52

May 18 (Reuters) - Protalix Biotherapeutics Inc
 PBDA.F :
    * PROTALIX BIOTHERAPEUTICS ANNOUNCES $20 MILLION MILESTONE
PAYMENT
FROM CHIESI GLOBAL RARE DISEASES
    * PROTALIX BIOTHERAPEUTICS - MILESTONE PAYMENT TRIGGERED BY
FDA
APPROVAL OF ELFABRIO (PEGUNIGALSIDASE ALFA-IWXJ) AND PAYABLE
WITHIN 30 DAYS OF APPROVAL
    * PROTALIX BIOTHERAPEUTICS - ON PROFORMA BASIS, INCLUDING
RECEIPT
OF $20.0 MILLION MILESTONE PAYMENT, CASH AND CASH EQUIVALENTS AS
OF MAY 18 IS $51.6 MILLION

Source text for Eikon:  ID:nPnnRcgha 
Further company coverage:  PBDA.F